vs

Side-by-side financial comparison of DigitalOcean Holdings, Inc. (DOCN) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

DigitalOcean Holdings, Inc. is the larger business by last-quarter revenue ($242.4M vs $186.7M, roughly 1.3× NEOGENOMICS INC). DigitalOcean Holdings, Inc. runs the higher net margin — 10.6% vs -57.9%, a 68.4% gap on every dollar of revenue. On growth, DigitalOcean Holdings, Inc. posted the faster year-over-year revenue change (18.3% vs 11.1%). Over the past eight quarters, DigitalOcean Holdings, Inc.'s revenue compounded faster (14.5% CAGR vs 6.5%).

DigitalOcean Holdings, Inc. is an American multinational technology company and cloud service provider. The company is headquartered in Broomfield, Colorado, US, with 15 globally distributed data centers. DigitalOcean provides developers, startups, and SMBs with cloud infrastructure-as-a-service platforms.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

DOCN vs NEO — Head-to-Head

Bigger by revenue
DOCN
DOCN
1.3× larger
DOCN
$242.4M
$186.7M
NEO
Growing faster (revenue YoY)
DOCN
DOCN
+7.2% gap
DOCN
18.3%
11.1%
NEO
Higher net margin
DOCN
DOCN
68.4% more per $
DOCN
10.6%
-57.9%
NEO
Faster 2-yr revenue CAGR
DOCN
DOCN
Annualised
DOCN
14.5%
6.5%
NEO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DOCN
DOCN
NEO
NEO
Revenue
$242.4M
$186.7M
Net Profit
$25.7M
$-108.0M
Gross Margin
58.7%
43.3%
Operating Margin
16.0%
46.9%
Net Margin
10.6%
-57.9%
Revenue YoY
18.3%
11.1%
Net Profit YoY
40.5%
42.0%
EPS (diluted)
$0.23
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOCN
DOCN
NEO
NEO
Q1 26
$186.7M
Q4 25
$242.4M
$190.2M
Q3 25
$229.6M
$187.8M
Q2 25
$218.7M
$181.3M
Q1 25
$210.7M
$168.0M
Q4 24
$204.9M
$172.0M
Q3 24
$198.5M
$167.8M
Q2 24
$192.5M
$164.5M
Net Profit
DOCN
DOCN
NEO
NEO
Q1 26
$-108.0M
Q4 25
$25.7M
Q3 25
$158.4M
$-27.1M
Q2 25
$37.0M
$-45.1M
Q1 25
$38.2M
$-25.9M
Q4 24
$18.3M
Q3 24
$32.9M
$-17.7M
Q2 24
$19.1M
$-18.6M
Gross Margin
DOCN
DOCN
NEO
NEO
Q1 26
43.3%
Q4 25
58.7%
43.8%
Q3 25
59.6%
42.8%
Q2 25
59.9%
42.6%
Q1 25
61.4%
43.6%
Q4 24
57.1%
44.9%
Q3 24
60.2%
44.6%
Q2 24
61.0%
44.1%
Operating Margin
DOCN
DOCN
NEO
NEO
Q1 26
46.9%
Q4 25
16.0%
-7.1%
Q3 25
19.6%
-14.4%
Q2 25
16.3%
-26.3%
Q1 25
17.9%
-16.6%
Q4 24
15.9%
-10.7%
Q3 24
12.4%
-12.6%
Q2 24
11.6%
-13.3%
Net Margin
DOCN
DOCN
NEO
NEO
Q1 26
-57.9%
Q4 25
10.6%
Q3 25
69.0%
-14.4%
Q2 25
16.9%
-24.9%
Q1 25
18.1%
-15.4%
Q4 24
8.9%
Q3 24
16.6%
-10.5%
Q2 24
9.9%
-11.3%
EPS (diluted)
DOCN
DOCN
NEO
NEO
Q1 26
$-0.13
Q4 25
$0.23
Q3 25
$1.51
Q2 25
$0.39
Q1 25
$0.39
Q4 24
$0.21
Q3 24
$0.33
Q2 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOCN
DOCN
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$254.5M
$146.1M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$-28.7M
$828.8M
Total Assets
$1.8B
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOCN
DOCN
NEO
NEO
Q1 26
$146.1M
Q4 25
$254.5M
$159.6M
Q3 25
$236.6M
$164.1M
Q2 25
$387.7M
$154.7M
Q1 25
$360.4M
$346.2M
Q4 24
$428.4M
$367.0M
Q3 24
$439.9M
$362.0M
Q2 24
$443.1M
$355.1M
Total Debt
DOCN
DOCN
NEO
NEO
Q1 26
Q4 25
$1.3B
$341.9M
Q3 25
$1.3B
Q2 25
Q1 25
Q4 24
$1.5B
$541.1M
Q3 24
Q2 24
Stockholders' Equity
DOCN
DOCN
NEO
NEO
Q1 26
$828.8M
Q4 25
$-28.7M
$836.6M
Q3 25
$-69.6M
$838.3M
Q2 25
$-175.2M
$854.0M
Q1 25
$-210.7M
$888.3M
Q4 24
$-203.0M
$902.3M
Q3 24
$-211.7M
$908.2M
Q2 24
$-253.8M
$915.9M
Total Assets
DOCN
DOCN
NEO
NEO
Q1 26
$1.3B
Q4 25
$1.8B
$1.4B
Q3 25
$1.7B
$1.4B
Q2 25
$1.7B
$1.4B
Q1 25
$1.6B
$1.6B
Q4 24
$1.6B
$1.6B
Q3 24
$1.5B
$1.6B
Q2 24
$1.5B
$1.6B
Debt / Equity
DOCN
DOCN
NEO
NEO
Q1 26
Q4 25
0.41×
Q3 25
Q2 25
Q1 25
Q4 24
0.60×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOCN
DOCN
NEO
NEO
Operating Cash FlowLast quarter
$57.3M
$-8.1M
Free Cash FlowOCF − Capex
$31.1M
FCF MarginFCF / Revenue
12.8%
Capex IntensityCapex / Revenue
10.8%
Cash ConversionOCF / Net Profit
2.23×
TTM Free Cash FlowTrailing 4 quarters
$180.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOCN
DOCN
NEO
NEO
Q1 26
$-8.1M
Q4 25
$57.3M
$1.3M
Q3 25
$95.8M
$8.9M
Q2 25
$92.4M
$20.3M
Q1 25
$64.1M
$-25.3M
Q4 24
$71.3M
$9.8M
Q3 24
$73.4M
$9.2M
Q2 24
$71.3M
$13.9M
Free Cash Flow
DOCN
DOCN
NEO
NEO
Q1 26
Q4 25
$31.1M
$-6.5M
Q3 25
$88.0M
$570.0K
Q2 25
$59.3M
$14.0M
Q1 25
$2.1M
$-29.8M
Q4 24
$26.1M
$-1.8M
Q3 24
$16.0M
$-1.6M
Q2 24
$39.5M
$814.0K
FCF Margin
DOCN
DOCN
NEO
NEO
Q1 26
Q4 25
12.8%
-3.4%
Q3 25
38.3%
0.3%
Q2 25
27.1%
7.7%
Q1 25
1.0%
-17.8%
Q4 24
12.7%
-1.0%
Q3 24
8.1%
-0.9%
Q2 24
20.5%
0.5%
Capex Intensity
DOCN
DOCN
NEO
NEO
Q1 26
Q4 25
10.8%
4.1%
Q3 25
3.4%
4.4%
Q2 25
15.2%
3.5%
Q1 25
29.4%
2.7%
Q4 24
22.1%
6.7%
Q3 24
28.9%
6.4%
Q2 24
16.6%
8.0%
Cash Conversion
DOCN
DOCN
NEO
NEO
Q1 26
Q4 25
2.23×
Q3 25
0.60×
Q2 25
2.50×
Q1 25
1.68×
Q4 24
3.91×
Q3 24
2.23×
Q2 24
3.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOCN
DOCN

Scalers$84.3M35%
Scalers Plus$69.9M29%
Builders$64.1M26%
Learners Testers And Other$24.1M10%

NEO
NEO

Segment breakdown not available.

Related Comparisons